Mirati, Revance price follow-ons

Mirati Therapeutics Inc. (NASDAQ:MRTX) and Revance Therapeutics Inc. (NASDAQ:RVNC) have each raised $100 million in follow-ons.

Mirati priced 1.6 million shares at $62 late on Jan. 16. The price is a slim discount to the company’s close of $62.47 on Jan. 16 when it proposed just after the bell to raise $75 million. J.P. Morgan, Citigroup, Cowen, Barclays and Credit Suisse are underwriters. As of Dec. 31, the company had $222.8 million in cash...